Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
80000383
Market status:
Not Marketed
Licence Status:
Active
Brand name(s):
Truehope EMP ;
EMPOWERPLUS Q96 ;
Wahre Gesundheit
Licence holder:
Synergy Group of Canada Inc.
Dosage Form:
Capsule
Recommended route of administration:

Oral

Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Adults 2.0 capsule 2 daily
Recommended use or purpose:
Nutritional support for mental and physical well-being.
Risk Information:
Cautions and Warnings 
If you are pregnant or breastfeeding, consult a healthcare practitioner prior to use. Consult a physician if you have any serious pre-existing health conditions.
Contra-Indications 
Phenylketonurics: contains phenylalanine.
Known Adverse Reactions 
The following side effects have been found to be "rare", "minor" and "transitory". These include: headaches, nausea, and flatuation.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
(2S)-2-Aminoglutaramic acid 10.0 mg
1alpha, 2alpha, 3alpha, 4beta, 5alpha, 6beta hexahydroxycyclohexane 10.0 mg
2-(Hydroxy)-N,N,N-triethylethanaminium bitartrate 30.0 mg
2-Amino-3-phenyl-propanoic acid 20.0 mg
Biotin 60.0 mcg
Bis(2-Carboxyethylgermaniumsesquioxide) 1.2 mg
Calcium 73.3 mg
Chromium 34.7 mcg
Citrus Bioflavonoids 13.3 mg
4 : 1
DHE: 53.2 mg
8.0   %
flavanones
1.0   %
flavones
1.0   %
flavanols
Copper 0.4 mg
D-Pantothenic acid 1.2 mg
Folate 80.0 mcg
Ginkgo biloba 2.0 mg
50 : 1
DHE: 100 mg
fluid
24.0   %
Ginko flavone glycosides
6.0   %
Terpene lactones
Iodine 11.3 mcg
Iron 0.8 mg
L-gamma-methylthio-alpha-aminobutyric acid 3.3 mg
Magnesium 33.3 mg
Manganese 0.5 mg
Molybdenum 8.0 mcg
Niacin 5.0 mg
Nickel 1.6 mcg
Phosphorus 46.7 mg
Potassium 13.3 mg
Riboflavin 0.8 mg
Selenium 11.3 mcg
Thiamine 1.0 mg
Vanadium 66.3 mcg
Vitamin A 96.0 mcg
320.0   IU
Vitamin B12 50.0 mcg
Vitamin B6 2.0 mg
Vitamin C 33.3 mg
Vitamin D 2.0 mcg
80.0   IU
Vitamin E 13.4 mg
20.0   IU
Vitis vinifera 2.5 mg
100 : 1
DHE: 250 mg
Zinc 2.7 mg
List of non-medicinal ingredients:
  • Gelatin
  • Magnesium Stearate
Date of licensing:
2005-05-04
Revised date of licence:
2014-02-21

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

"Page details"

Date modified: